Insider Buy/Sell Details for the Biotechnology Industry — April 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1126)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,360
Price
$577.62
Total Value
$785.57K
Shares Held After
47,889
% of Holdings
2.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$575.89
Total Value
$46.07K
Shares Held After
49,249
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
404
Price
$575.25
Total Value
$232.40K
Shares Held After
49,329
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$574.25
Total Value
$160.79K
Shares Held After
49,733
% of Holdings
0.6%
Alzamend Neuro, Inc. (ALZN)
AULT MILTON C III — Director
Shares
108,388
Price
$1.00
Total Value
$108.90K
Shares Held After
116,648
% of Holdings
92.9%
Onconetix, Inc. (ONCO)
HRT FINANCIAL LP — 10% Owner
Shares
74,350
Price
$0.77
Total Value
$57.25K
Shares Held After
104,498
% of Holdings
71.1%
Travere Therapeutics, Inc. (TVTX)
Inrig Jula — CHIEF MEDICAL OFFICER
Shares
7,215
Price
$41.93
Total Value
$302.52K
Shares Held After
112,491
% of Holdings
6.0%
Travere Therapeutics, Inc. (TVTX)
Cline Christopher R. — CHIEF FINANCIAL OFFICER
Shares
7,239
Price
$41.93
Total Value
$303.52K
Shares Held After
117,913
% of Holdings
5.8%
Travere Therapeutics, Inc. (TVTX)
Cline Christopher R. — CHIEF FINANCIAL OFFICER
Shares
9
Price
$41.07
Total Value
$369.63
Shares Held After
125,152
% of Holdings
0.0%
Travere Therapeutics, Inc. (TVTX)
REED ELIZABETH E — Chief Legal Officer and GC
Shares
7,215
Price
$41.93
Total Value
$302.52K
Shares Held After
111,996
% of Holdings
6.1%
Travere Therapeutics, Inc. (TVTX)
REED ELIZABETH E — Chief Legal Officer and GC
Shares
37,500
Price
$41.07
Total Value
$1.54M
Shares Held After
119,211
% of Holdings
23.9%
Travere Therapeutics, Inc. (TVTX)
Heerma Peter — CHIEF COMMERCIAL OFFICER
Shares
7,215
Price
$41.93
Total Value
$302.52K
Shares Held After
138,608
% of Holdings
4.9%
Whitehawk Therapeutics, Inc. (WHWK)
BALL BRYAN — Chief Technical Operations Officer and SVP, Manufacturing Operations
Shares
92,460
Price
$3.64
Total Value
$336.55K
Shares Held After
397,106
% of Holdings
18.9%
Genprex, Inc. (GNPX)
LONGNECKER BRENT M — Director
Shares
10
Price
$1.23
Total Value
$12.30
Shares Held After
0
% of Holdings
100.0%
Genprex, Inc. (GNPX)
LONGNECKER BRENT M — Director
Shares
8
Price
$1.23
Total Value
$9.84
Shares Held After
9,157
% of Holdings
0.1%
Vor Biopharma Inc. (VOR)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
153,735
Price
$15.97
Total Value
$2.46M
Shares Held After
3,251,263
% of Holdings
4.5%
Vera Therapeutics, Inc. (VERA)
Fordyce Marshall — Director
Shares
900
Price
$45.51
Total Value
$40.96K
Shares Held After
235,244
% of Holdings
0.4%
Vera Therapeutics, Inc. (VERA)
Fordyce Marshall — Director
Shares
7,921
Price
$44.58
Total Value
$353.11K
Shares Held After
236,144
% of Holdings
3.2%
Vera Therapeutics, Inc. (VERA)
Fordyce Marshall — Director
Shares
14,130
Price
$43.66
Total Value
$616.99K
Shares Held After
244,065
% of Holdings
5.5%
Monte Rosa Therapeutics, Inc. (GLUE)
Warmuth Markus — Director
Shares
8,000
Price
$17.64
Total Value
$141.12K
Shares Held After
605,471
% of Holdings
1.3%
COMPUGEN LTD (CGEN)
Levine Zurit — SVP, Business Development
Shares
2,000
Price
$2.80
Total Value
$5.60K
Shares Held After
29,375
% of Holdings
6.4%
COMPUGEN LTD (CGEN)
Ophir Eran — Director
Shares
5,000
Price
$2.90
Total Value
$14.52K
Shares Held After
11,375
% of Holdings
30.5%
Rapport Therapeutics, Inc. (RAPP)
Yeleswaram Krishnaswamy — Chief Development Officer
Shares
10,200
Price
$35.08
Total Value
$357.80K
Shares Held After
266,651
% of Holdings
3.7%
Mineralys Therapeutics, Inc. (MLYS)
Congleton Jon — Director
Shares
15,730
Price
$26.83
Total Value
$421.98K
Shares Held After
689,321
% of Holdings
2.2%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
14,058
Price
$26.54
Total Value
$373.09K
Shares Held After
76,140
% of Holdings
15.6%
Travere Therapeutics, Inc. (TVTX)
Cline Christopher R. — CHIEF FINANCIAL OFFICER
Shares
65
Price
$28.85
Total Value
$1.88K
Shares Held After
125,161
% of Holdings
0.1%
Whitehawk Therapeutics, Inc. (WHWK)
BALL BRYAN — Chief Technical Operations Officer and SVP, Manufacturing Operations
Shares
26,389
Price
$3.46
Total Value
$91.31K
Shares Held After
489,566
% of Holdings
5.1%
Disc Medicine, Inc. (IRON)
Savage William Jacob — Chief Medical Officer
Shares
2,200
Price
$66.81
Total Value
$146.98K
Shares Held After
79,480
% of Holdings
2.7%
Disc Medicine, Inc. (IRON)
Savage William Jacob — Chief Medical Officer
Shares
3,531
Price
$66.12
Total Value
$233.47K
Shares Held After
81,680
% of Holdings
4.1%
Vor Biopharma Inc. (VOR)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
530,610
Price
$16.15
Total Value
$8.57M
Shares Held After
3,404,998
% of Holdings
13.5%
Liquidia Corp (LQDA)
Moomaw Scott — Chief Commercial Officer
Shares
1,686
Price
$38.20
Total Value
$64.41K
Shares Held After
184,558
% of Holdings
0.9%
Liquidia Corp (LQDA)
Moomaw Scott — Chief Commercial Officer
Shares
8,861
Price
$38.37
Total Value
$340.00K
Shares Held After
186,244
% of Holdings
4.5%
Liquidia Corp (LQDA)
Krepp Sarah — Chief Human Resource Officer
Shares
4,557
Price
$38.37
Total Value
$174.85K
Shares Held After
147,019
% of Holdings
3.0%
Liquidia Corp (LQDA)
Adair Jason — Chief Business Officer
Shares
7,301
Price
$38.37
Total Value
$280.14K
Shares Held After
215,426
% of Holdings
3.3%
Liquidia Corp (LQDA)
Schundler Russell — General Counsel
Shares
13,692
Price
$38.37
Total Value
$525.36K
Shares Held After
610,532
% of Holdings
2.2%
Liquidia Corp (LQDA)
JEFFS ROGER — Director
Shares
32,744
Price
$38.37
Total Value
$1.26M
Shares Held After
1,137,599
% of Holdings
2.8%
Liquidia Corp (LQDA)
Kaseta Michael — CFO and COO
Shares
18,958
Price
$38.37
Total Value
$727.42K
Shares Held After
405,775
% of Holdings
4.5%
Liquidia Corp (LQDA)
Saggar Rajeev — Chief Medical Officer
Shares
9,220
Price
$38.37
Total Value
$353.77K
Shares Held After
173,270
% of Holdings
5.1%
Liquidia Corp (LQDA)
Boyle Dana — Chief Accounting Officer
Shares
5,101
Price
$38.37
Total Value
$195.73K
Shares Held After
176,918
% of Holdings
2.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$579.53
Total Value
$115.91K
Shares Held After
40,513
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
384
Price
$578.52
Total Value
$222.15K
Shares Held After
40,713
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,475
Price
$577.32
Total Value
$851.54K
Shares Held After
41,097
% of Holdings
3.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,081
Price
$576.36
Total Value
$623.04K
Shares Held After
42,572
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,850
Price
$575.31
Total Value
$1.06M
Shares Held After
43,653
% of Holdings
4.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,370
Price
$574.25
Total Value
$786.72K
Shares Held After
45,503
% of Holdings
2.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,235
Price
$573.39
Total Value
$708.13K
Shares Held After
46,873
% of Holdings
2.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
945
Price
$572.39
Total Value
$540.91K
Shares Held After
48,108
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
925
Price
$571.39
Total Value
$528.53K
Shares Held After
49,053
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
35
Price
$569.78
Total Value
$19.94K
Shares Held After
49,978
% of Holdings
0.1%
Rapport Therapeutics, Inc. (RAPP)
Yeleswaram Krishnaswamy — Chief Development Officer
Shares
9,165
Price
$34.97
Total Value
$320.54K
Shares Held After
276,851
% of Holdings
3.2%
Showing 301–350 of 1126 transactions (page 7 of 23)